209 related articles for article (PubMed ID: 1691452)
1. Role of a subdomain in the folding of bovine pancreatic trypsin inhibitor.
Staley JP; Kim PS
Nature; 1990 Apr; 344(6267):685-8. PubMed ID: 1691452
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the (30-51, 14-38) two-disulphide folding intermediates of the homologous proteins dendrotoxin K and bovine pancreatic trypsin inhibitor by two-dimensional 1H nuclear magnetic resonance.
Kortemme T; Hollecker M; Kemmink J; Creighton TE
J Mol Biol; 1996 Mar; 257(1):188-98. PubMed ID: 8632454
[TBL] [Abstract][Full Text] [Related]
3. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
Ma LC; Anderson S
Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
[TBL] [Abstract][Full Text] [Related]
4. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes.
Creighton TE; Bagley CJ; Cooper L; Darby NJ; Freedman RB; Kemmink J; Sheikh A
J Mol Biol; 1993 Aug; 232(4):1176-96. PubMed ID: 7690407
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR analysis of the partly-folded non-native two-disulphide intermediates (30-51,5-14) and (30-51,5-38) in the folding pathway of bovine pancreatic trypsin inhibitor.
van Mierlo CP; Kemmink J; Neuhaus D; Darby NJ; Creighton TE
J Mol Biol; 1994 Jan; 235(3):1044-61. PubMed ID: 7507172
[TBL] [Abstract][Full Text] [Related]
6. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates.
Darby NJ; Morin PE; Talbo G; Creighton TE
J Mol Biol; 1995 Jun; 249(2):463-77. PubMed ID: 7540214
[TBL] [Abstract][Full Text] [Related]
7. Phi-values for BPTI folding intermediates and implications for transition state analysis.
Bulaj G; Goldenberg DP
Nat Struct Biol; 2001 Apr; 8(4):326-30. PubMed ID: 11276252
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor. Forming the first disulphide bonds in analogues of the reduced protein.
Darby NJ; Creighton TE
J Mol Biol; 1993 Aug; 232(3):873-96. PubMed ID: 7689114
[TBL] [Abstract][Full Text] [Related]
9. Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
Kibria FM; Lees WJ
J Am Chem Soc; 2008 Jan; 130(3):796-7. PubMed ID: 18166059
[TBL] [Abstract][Full Text] [Related]
10. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements.
van Mierlo CP; Darby NJ; Keeler J; Neuhaus D; Creighton TE
J Mol Biol; 1993 Feb; 229(4):1125-46. PubMed ID: 7680380
[TBL] [Abstract][Full Text] [Related]
11. Efficient catalysis of disulphide bond rearrangements by protein disulphide isomerase.
Weissman JS; Kim PS
Nature; 1993 Sep; 365(6442):185-8. PubMed ID: 7690463
[TBL] [Abstract][Full Text] [Related]
12. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI.
Chang JY
Biochemistry; 1996 Sep; 35(36):11702-9. PubMed ID: 8794751
[TBL] [Abstract][Full Text] [Related]
13. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
Kuroda Y; Kim PS
J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic interactions accelerate early stages of the folding of BPTI.
Dadlez M
Biochemistry; 1997 Mar; 36(10):2788-97. PubMed ID: 9062106
[TBL] [Abstract][Full Text] [Related]
15. Structure of a hydrophobically collapsed intermediate on the conformational folding pathway of ribonuclease A probed by hydrogen-deuterium exchange.
Houry WA; Scheraga HA
Biochemistry; 1996 Sep; 35(36):11734-46. PubMed ID: 8794754
[TBL] [Abstract][Full Text] [Related]
16. Conformation of native, reduced and [5-55]Ala bovine pancreatic trypsin inhibitor in the gas phase.
Nesatiy V; Chen YL; Collings BA; Douglas DJ
Rapid Commun Mass Spectrom; 1998; 12(1):40-4. PubMed ID: 9450353
[TBL] [Abstract][Full Text] [Related]
17. Stability of the residual structure in unfolded BPTI in different conditions of temperature and solvent composition measured by disulphide kinetics and double mutant cycle analysis.
Zdanowski K; Dadlez M
J Mol Biol; 1999 Mar; 287(2):433-45. PubMed ID: 10080904
[TBL] [Abstract][Full Text] [Related]
18. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding.
Dadlez M; Kim PS
Biochemistry; 1996 Dec; 35(50):16153-64. PubMed ID: 8973187
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
Bulaj G; Goldenberg DP
J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
[TBL] [Abstract][Full Text] [Related]
20. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
Krokoszynska I; Dadlez M; Otlewski J
J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
